Can Quetiapine (Seroquel) cause hallucinations and confusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Quetiapine (Seroquel) and Its Relationship to Hallucinations and Confusion

Quetiapine (Seroquel) can cause hallucinations and confusion as adverse effects, particularly in elderly patients or those with pre-existing cognitive impairment, and these symptoms are recognized clinical features of drug-induced delirium. 1

Mechanism and Clinical Presentation

Quetiapine is an atypical antipsychotic commonly used to treat schizophrenia, bipolar disorder, and other psychiatric conditions. While it's designed to treat psychotic symptoms, it can paradoxically cause or worsen cognitive disturbances in certain populations:

  • Delirium features: Quetiapine-induced cognitive disturbances may present with:

    • Perceptual disturbances including hallucinations (usually visual or tactile)
    • Confusion and disorientation
    • Impaired attention and awareness
    • Disorganized thought processes
    • Language disturbances
    • Sleep-wake cycle disturbances 1
  • Presentation patterns: Symptoms may follow:

    • Rapid development (hours to days)
    • Fluctuating severity throughout the day (often worse in evening/night)
    • Varying psychomotor patterns (hyperactive, hypoactive, or mixed) 1

Risk Factors

Several factors increase the risk of quetiapine-induced hallucinations and confusion:

  • Age: Elderly patients are particularly vulnerable due to age-related changes in brain neurochemistry and drug metabolism 2
  • Polypharmacy: Concurrent use of multiple medications with anticholinergic properties
  • Dosing issues: Rapid dose escalation or excessive dosing
  • Medical comorbidities: Especially electrolyte disturbances, infections, or brain metastases 1
  • Pre-existing cognitive impairment: Patients with dementia or other neurological disorders

Management Approach

When hallucinations and confusion occur with quetiapine:

  1. Recognize the symptoms: Use standardized assessment tools like the Confusion Assessment Method (CAM-ICU) to identify delirium 1

  2. Address reversible causes:

    • Consider drug-induced delirium as a potential cause
    • Evaluate for other contributing factors (electrolyte disturbances, infections, etc.) 1
  3. Medication management:

    • Reduce or discontinue quetiapine if it's suspected as the cause
    • Consider dose reduction rather than complete discontinuation if quetiapine is essential for treatment
    • Avoid abrupt discontinuation to prevent withdrawal symptoms 3
  4. Alternative management:

    • If antipsychotic treatment is still needed, consider switching to a different agent with lower risk of cognitive side effects
    • For severe agitation with hallucinations, haloperidol may be considered at 0.5-1 mg initially (maximum 5 mg/day) 3

Prevention Strategies

To minimize the risk of quetiapine-induced hallucinations and confusion:

  • Start low, go slow: Begin with low doses (especially in elderly) and titrate gradually
  • Regular monitoring: Assess for early signs of cognitive changes
  • Medication review: Minimize polypharmacy, especially anticholinergic burden
  • Patient education: Inform patients and caregivers about potential symptoms to report

Important Considerations

  • While quetiapine is often considered to have a relatively benign side effect profile compared to conventional antipsychotics 4, cognitive disturbances remain a significant concern, particularly in vulnerable populations
  • Paradoxically, quetiapine is sometimes used to treat delirium, yet it can itself cause delirium-like symptoms
  • The risk of cognitive side effects must be balanced against the benefits in treating the underlying psychiatric condition
  • Symptoms typically resolve with dose reduction or discontinuation, but may persist longer in elderly patients 1

By recognizing the potential for quetiapine to cause hallucinations and confusion, clinicians can monitor patients appropriately and intervene promptly when these adverse effects occur.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Agitation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Quetiapine fumarate (Seroquel): a new atypical antipsychotic.

Drugs of today (Barcelona, Spain : 1998), 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.